🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Es seguro, aunque no (parece) mejor - Antihypertensive Medication Timing and Cardiovascular Events and Death jamanetwork.com/journals/jama/…

Amilorida, puede ser una opcion - Spironolactone vs Amiloride for Resistant Hypertension jamanetwork.com/journals/jama/…

El RCV aumenta tras recibir tratamiento sistémico para #cáncer, pero varia el tipo de problema CV según el cáncer sufrido - Risk of Cardiovascular Disease in Cancer Survivors after Systemic Treatment: A Population-Based Cohort Study | JACC: CardioOncology jacc.org/doi/10.1016/j.…

La comida es medicina - A Systematic Review of “Food Is Medicine” Randomized Controlled Trials for Noncommunicable Disease in the United States: A Scientific Statement From the American Heart Association | Circulation ahajournals.org/doi/10.1161/CI…

📉Lower LDL-C for longer is better. The NLA’s new guidance simplifies LDL-C management for adults — helping clinicians & patients improve evidence-based measurement and treatment of LDL-C. Read the guidelines & recommendations: lipidjournal.com/article/S1933-…. Beth Jackson Christie Ballantyne

Diabetes Deprescribing in Older Adults jamanetwork.com/journals/jamai…

Una eficacia espectacular para evitar el #VRS

En #diabetes 2, insulina #efsitora es no inferior a degludec y tampoco a glargina U100, aunque tiene algo más de tendencia a la hipoglucemia, sobre todo en las primeras semanas.. QWINT-3 y QWINT-4 thelancet.com/journals/lance… thelancet.com/journals/lance… thelancet.com/journals/lance…

La diabetes gestacional representa un marcador de salud Cardiovascular previo al embarazo y enfatiza la importancia de mejorarla precozmente antes del embarazo - Prepregnancy Cardiovascular Health, Gestational Diabetes, and Coronary Artery Calcium jamanetwork.com/journals/jamac…

Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study) mdpi.com/2898570 #mdpinutrients a través de Nutrients MDPI Irene Caballero

Cuidado. La terapia con Tirzepatide dio lugar a un aumento significativo de las probabilidades de incidencia de PDR, particularmente en individuos con NPDR leve con maculopatía (grado R1M1), o NPDR moderado a grave con o sin maculopatía (grado R2M0, R2M1). link.springer.com/article/10.100…

Cuida tus factores de riesgo cardiovascular y vivirás más años y mejor. Global Effect of Cardiovascular Risk Factors on Lifetime Estimates | New England Journal of Medicine nejm.org/doi/full/10.10…

No nos olvidemos del control tensional en la ERC. Intensive Systolic Blood Pressure Reduction and Kidney and Cardiovascular Outcomes jamanetwork.com/journals/jaman…

Triple Assessments of Atherosclerosis in Patients With Heterozygous Familial Hypercholesterolemia | JACC: Asia jacc.org/doi/10.1016/j.… Clara Viñals

Discordance of Small Dense LDL Cholesterol Beyond LDL Cholesterol or Non–HDL Cholesterol and Carotid Plaque | JACC: Asia jacc.org/doi/10.1016/j.…

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial - The Lancet thelancet.com/journals/lance…

Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study - The Lancet thelancet.com/journals/lance…

La obesidad nos hace envejecer antes, o más rápidamente. Long-Term Obesity and Biological Aging in Young Adults jamanetwork.com/journals/jaman…

arGLP1 (Dula y Semaglutide) se posicionan cómo fármacos más eficaces para el control de ulceración y reducción de amputaciones vs SGLT2, en población de alto riesgo con DM2. Estudio de cohortes #piediabetico doi.org/10.2337/dc25-0…

Glucagon-Like Peptide-1 Receptor Agonists and Risk for Gastroesophageal Reflux Disease in Patients With Type 2 Diabetes: A Population-Based Cohort Study: Annals of Internal Medicine: Vol 0, No 0 acpjournals.org/doi/10.7326/AN…